Linda Grais

Linda Grais is a biotech executive with over 25 years of experience in the industry. Linda is currently the Director at ARCA biopharma, and has previously held leadership positions at Ocera Therapeutics, Inc., InterWest Partners, SGX Pharmaceuticals, and Wilson Sonsini Goodrich & Rosati.

Linda has a proven track record of success in both startup and publicly-traded companies. Linda was responsible for leading the investments in biopharmaceutical and medical device companies as a Partner at InterWest Partners. Linda also served on the boards of directors of several portfolio companies, including a company listed on NASDAQ.

In 1997, Linda co-founded SGX Pharmaceuticals, where they developed the company's operating plan and business model, recruited the team, and raised $85 million in venture capital. The company went public and was later acquired by Eli Lilly.

Linda began their career as an attorney at Wilson Sonsini Goodrich & Rosati, where they specialized in corporate development.

Linda Grais is a highly accomplished biotech executive with a long history of successful leadership roles in both startup and publicly-traded companies.

Linda Grais attended Yale University for their undergraduate degree, where they studied philosophy. Linda then attended Stanford Law School for their Juris Doctor. Lastly, they attended Yale University School of Medicine for their Doctor of Medicine.